News and Trends 17 Jul 2020 Russian Hackers Launch Cyber Attack on Covid-19 Vaccine Developers The National Cyber Security Centre (NCSC) in the UK stated this week that several organizations involved in Covid-19 vaccine development in the UK, US, and Canada have been targeted in… July 17, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 13 Oct 2016 This Start-up sells Cheap 3D-printed Microscopes for Bacterial testing What if you could print your own microscope to save money? WaterScope has designed a 3D-printed microscope for rapid water testing in the field on a budget. WaterScope is a… October 13, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Oct 2018 Microsoft Signs its First Microbiome Partnership Microsoft Genomics will work with Cambridge-based Eagle Genomics to scale up its artificial intelligence platform for microbiome research. In recent years, it has become evident that the microbes that inhabit… October 15, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 8 Mar 2023 New bone cancer drug could save children’s lives Researchers at the University of East Anglia (UEA) in the U.K. have developed a new drug that works against all of the main types of primary bone cancer. Cancer that… March 8, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 14 Sep 2022 Rivaling the Golden Triangle at Bristol’s Science Creates hub September 15th 2022: Article updated to include comments from Harry Destecroix and to correct a mispelling of Science Creates. The Golden Triangle region hosts much of the U.K.’s biotech innovation…. September 14, 2022 - 9 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jan 2023 BiVictriX announces positive data from leukemia study BiVictriX Therapeutics plc has announced positive in vivo data from a toxicity evaluation study with BVX001, the company’s lead program, compared to gemtuzumab ozogamicin (GO). GO, marketed as Mylotarg, is… January 31, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 20 May 2019 Update: British RNA Biotech Increases Series A to €34M Update (20/05/19): Storm Therapeutics has increased its series A financing round by an additional €16M (£14M) to €34M (£30M), which the company plans to use to advance its pipeline of… May 20, 2019 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Best in Biotech 6 Oct 2022 15 biotech companies shaking up the scene in Cambridge This article was originally published in December 2020 and has since been updated. Cambridge has a large biotech scene that is starting to rival that of its U.S. namesake. Here… October 6, 2022 - 9 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
More News! 4 Nov 2022 Alimentiv and Summit collaborate to tackle liver disease NASH Drug development programs will be driven forward by a collaboration between Alimentiv Inc. and Summit Clinical Research, in a bid to tackle non-alcoholic steatohepatitis (NASH). They announced a strategic alliance… November 4, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 15 Nov 2022 Researchers create mini ‘bone marrow in a dish’ to boost anti-cancer treatments Scientists from Oxford University and the University of Birmingham in the U.K. have made the first bone marrow ‘organoids’ that capture the key features of human bone marrow. The technology,… November 15, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Expert Advice 2 May 2022 Chief Business Officers: Shedding Light on Biotech’s Dealmakers In addition to helping patients, biotech companies need to focus on the commercial potential of their work. Stephanie Bewick at Destiny Pharma outlines her experiences of how a Chief Business… May 2, 2022 - 5 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 22 Jul 2022 Consortium awarded €4M towards platform for personalized cell therapies A company developing precision T cell therapies that treat solid tumors announced yesterday (July 21) it is leading a consortium that has been awarded a €4 million ($4.2 million) grant… July 22, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email